Weekly Venture Capital Activity Week April 30, 2004 through May 6, 2004

Over $235 million of venture capital was invested in 20 U.S.-based companies during this reporting period. The average deal size was approximately $11.75 million. The amount of venture capital invested this period is down by 39% from last weeks $387 million.

(PRWEB) May 10, 2004 --Venture Capital Investments by Region

Geographically, 4 Massachusetts companies raised $79 million in venture financings. The largest venture financing in Massachusetts this period was into Microbia, Inc for $40 million. Microbia, Inc is a Cambridge based company that develops antimicrobial/antifungal drugs and microbial drug production treating biofilm surface-attached sources of pathogens.

Venture Capital Investments by Sector

The biotechnology sector raised 51% of the venture capital this period. 4 biotechnology companies raised over $120 million in venture financings. The largest venture financings are by two biotechnology companies this reporting period: Acologix, Inc. and by Microbia, Inc. for $40 million each. Acologix, Inc. is headquartered in Emeryville, CA and targets the treatment of the diseases and disorders in "osteo-renal" area that are osteoporosis, periodontal/dental diseases, chronic renal failure, and others.

Venture Capital Investments by Round

Companies raising their Series B round led this weeks venture capital activity. Series B companies represented 37% of the total venture capital deployed this period. The largest Series B financing was into Acologix, Inc.

Top Three Venture Capital Investments

The three largest venture deals this period are as follows:

1.   Acologix
2.   Microbia
3.   Merrimack Pharmaceuticals

Venture Capitalists funding the Top Three Deals

The following eighteen investors funded the above mentioned top three venture capital investments in excess of $108 million:

1.   Nomura Securities International
2.   SOFTBANK Capital Partners
3.   Tokio Marine and Fire Insurance
4.   AquaRIMCO
5.   Nomura Research and Advisory
6.   SMBC Capital
7.   JAIC America
8.   Wharton Biotechnology Partners
9.   Sorenson Development Inc.
10.   Unilever Technology Ventures
11.   GTC Biotherapeutics
12.   MS Seed Capital
13.   Paperboy Ventures
14.   Invus Group
15.   Bio One Capital
16.   Singapore EDB
17.   Alton
18.   Linkagene

A total of 57 equity financings of private and public companies occurred during this reporting period. Each of the 57 equity financings are profiled in a weekly report as well as over 30,000 other historic equity financings that you can obtain as a subscriber.
    
About Capital Hunter

Capital Hunter is a financial information service company that collects and disseminates data on investors and their corresponding equity financings. The company also provides a searchable database of historic financings, weekly financing reports, and quarterly studies.

Prepared by: Dante Fichera